Skip to main content
search

Date: May 28, 2025

Time: 11:00 am to 12:00 pm ET

Summary

Join our exclusive webinar—brought to you by Certara and RAPS—to discover how leading regulatory writing and operations can transform your approach, helping you bring therapies to patients faster while surpassing global compliance standards. This webinar is worth 1 RAC credit.

Accelerate drug approvals in an evolving regulatory world

Is your team ready to drive innovation and stay ahead in the fast-shifting world of drug development?

What you’ll learn:

  • Raise the Bar in Regulatory Writing: See how visionary approaches produce crystal-clear Clinical Study Reports, Common Technical Document (CTD) modules, and Risk Management Plans that shape decision-making and speed up approvals.
  • Build Trust through Transparency: Explore the impact of compelling patient narratives and accessible lay summaries in meeting evolving regulatory requirements and fostering public confidence.
  • Unlock Technology’s Power: Get hands-on with the latest advancements, including electronic CTD (eCTD) submissions, automation, and structured content management systems that make global workflows more agile than ever.
  • Operational Strategies for Tomorrow: Learn about breakthrough tactics like simultaneous multi-agency submissions and proactive compliance with EMA Policy 0070 to reduce delays and accelerate timelines.
  • Empower Your Teams for Impact: Discover real-world strategies for enabling your regulatory teams to deliver life-changing therapies confidently and efficiently, even in the most complex landscapes.

Why attend?

This webinar is designed for forward-thinking regulatory professionals. Arm yourself with the knowledge, technology insights, and operational tools to redefine what’s possible in drug development.

Secure your spot today and get ready to redefine the future of regulatory excellence.

Speakers:

Evan Richardson, Senior Director, Transparency and Disclosure at Certara
Evan Richardson

Senior Director, Regulatory Operations and Clinical Disclosure, Certara

A seasoned pharmaceutical industry veteran, Evans Richardson brings nearly 20 years of experience spanning drugs, biologics, and medical devices. He’s worked with organizations of all sizes, both within industry and at service providers, developing a broad skillset encompassing regulatory affairs and operations, clinical disclosure, quality management, and project management. Currently, he leads a global team of subject matter experts at Certara, helping clients navigate electronic regulatory submissions and clinical data disclosure requirements.

Mark Bowlby, Senior Director, Global Submissions at Certara
Mark Bowlby, PhD

Senior Director, Global Submissions, Certara

Dr. Bowlby has over 25 years of experience in the clinical research and drug development industry. During the last 10 years, he has led many New Drug Applications, Biologics License Applications, and Investigational New Drug (IND) submissions to the Food and Drug Administration and European Medicines Agency. Dr. Bowlby has led the authoring of Investigator’s Brochures (IBs), clinical study reports (CSRs), clinical summaries and overviews, briefing packages, and other regulatory documents. Earlier in his career, Dr. Bowlby planned and wrote numerous biomedical manuscripts, posters, and slides regarding his scientific research and postdoctoral work at Harvard Medical School. His therapeutic areas of expertise include ophthalmology, neurology, psychiatry, and chronic pain. Dr. Bowlby has an expert understanding of drug discovery and development approaches used in the current biopharmaceutical environment.